Virbac (Virbac) Days Sales Outstanding

: 47.56 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

Virbac's average Accounts Receivable for the six months ended in Jun. 2023 was $172 Mil. Virbac's Revenue for the six months ended in Jun. 2023 was $661 Mil. Hence, Virbac's Days Sales Outstanding for the six months ended in Jun. 2023 was 47.56.

The historical rank and industry rank for Virbac's Days Sales Outstanding or its related term are showing as below:

VRBCF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 35.86 Med: 48.16 Max: 62.69
Current: 49.02

During the past 13 years, Virbac's highest Days Sales Outstanding was 62.69. The lowest was 35.86. And the median was 48.16.

VRBCF's Days Sales Outstanding is ranked better than
72.2% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 72.185 vs VRBCF: 49.02

Virbac's Days Sales Outstanding increased from Jun. 2022 (41.59) to Jun. 2023 (47.56).

Virbac Days Sales Outstanding Historical Data

The historical data trend for Virbac's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

46.00

39.54

37.60

37.20

39.14

Virbac Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Sales Outstanding																41.65	43.62	41.59	47.48	47.56

Competitive Comparison

For the Drug Manufacturers - General subindustry, Virbac's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Virbac Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, Virbac's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Virbac's Days Sales Outstanding falls into.

Virbac Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Virbac's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (121.318	+	154.968)	/	2 )	/	1288.334	*	365
=	138.143					/	1288.334	*	365
=	39.14

Virbac's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (154.968	+	189.719)	/	2 )	/	661.395	*	365 / 2
=	172.3435					/	661.395	*	365 / 2
=	47.56

Virbac (OTCPK:VRBCF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Virbac Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Virbac's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac (Virbac) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

0NM7:UK VIRP:France V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.